Clinical Trial Update: A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis [Phase 2]

View source ↗

Summary

The document notes the Phase IIb trial of OligoG in subjects with cystic fibrosis has completed status (COMPLETED) according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• OligoG (oligoG)

Snippet

Sponsor: AlgiPharma AS | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED